Page last updated: 2024-08-05 13:44:16
dacarbazine
A monocarboxylic acid amide that is 1H-imidazole-4-carboxamide which is substituted at position 5 by a 3,3-dimethyltriaz-1-en-1-yl group. It is used for the treatment of metastatic malignant melanoma, and in combination with other drugs for the treatment of Hodgkin's disease and soft-tissue sarcoma.
ChEBI ID: 4305
Members (1)
Research
Studies (7,204)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
pre-1990 | 916 (12.72) | 18.7374 |
1990's | 757 (10.51) | 18.2507 |
2000's | 1,775 (24.64) | 29.6817 |
2010's | 3,385 (46.99) | 24.3611 |
2020's | 371 (5.15) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
Trials | 1,463 (19.36%) | 5.53% |
Reviews | 787 (10.42%) | 6.00% |
Case Studies | 1,122 (14.85%) | 4.05% |
Observational | 17 (0.22%) | 0.25% |
Other | 4,167 (55.15%) | 84.16% |